Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis. [electronic resource]
Producer: 20100527Description: 3088-97 p. digitalISSN:- 1538-8514
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Inducing Factor -- metabolism
- Blotting, Western
- Depsipeptides -- administration & dosage
- Drug Synergism
- Fas-Associated Death Domain Protein -- metabolism
- Histone Deacetylase Inhibitors -- administration & dosage
- Histone Deacetylases -- metabolism
- Humans
- Intracellular Signaling Peptides and Proteins -- metabolism
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Phosphorylation -- drug effects
- Protein Kinase C -- metabolism
- Protein Kinase C beta
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 -- metabolism
- Protein-Tyrosine Kinases -- metabolism
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- Receptors, Tumor Necrosis Factor -- metabolism
- Signal Transduction -- drug effects
- Syk Kinase
- TNF-Related Apoptosis-Inducing Ligand -- administration & dosage
- Tetradecanoylphorbol Acetate -- pharmacology
- Tumor Cells, Cultured
- src-Family Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.